Reactions 1680, p19 - 2 Dec 2017 Creatine kinase increased: case report A real-world retrospective clinical study described a patient [age and sex not stated], who showed increased creatine kinase during the two-year combination therapy treatment with adefovir and entecavir for chronic hepatitis B [route, dosage, duration of treatment to reaction onset and outcome not stated]. Author comment: "After a detailed evaluation, only 14 patients with CK elevations should be considered indicative of drug-related side effects, [. . .] 1 patient in entecavir + adefovir". Wang M-L, et al. Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy. Journal of Viral Hepatitis 24 (Suppl. 1): 21-28, Nov 2017. Available from: URL: http://doi.org/10.1111/jvh.12792 - China 803286288 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera